What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Mon Sep 13 EDT - Wed Sep 15 EDT (about 1 year ago)
Location Online
Region All

Connecting Early Stage Products with Capital & Channel Partners

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Who Should Attend?
RESI is committed to facilitating conversations that spark early-stage deals in across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table. In the past 7 years, over 300 companies have raised $400+ MM through 30 RESI Conferences. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and potentially, secure funding from Seed to Series B.

300-450+ Investors & Strategic Partners
Investors get a front-row seat to emerging early-stage companies, with direct insight into product pipelines, licensing opportunities, financing rounds, technologies, licensing deals, and management details in order to find the best fit for their theme.

300-450+ Start-Ups & Fundraising Executives
Life science and healthcare fundraising CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development through a match-based partnering system, pitch session opportunities, and industry expert panels.

100-200+ Service Providers
Deal-making is not just a two-way street. The early-stage arena can be challenging to navigate without the help of law firms, broker-dealers, CROs/CMOs, and consulting services to assist in bringing a bright prospect to market.


2021 Speakers

Chris Haskell
VP, Head of West Coast Innovation Center, Bayer

Meghan Zubradt
Senior Manager, Transactions, Johnson & Johnson Innovation (JLABS)

João Ribas
Associate, Novo Holdings A/S

Catello Somma
Associate, TVM Capital Life Science

Kristin King
Member, Boston Harbor Angels

Ruchi Dana
Board Member, DANA Group of Companies

Katherine Hill Ritchie
Director, Nottingham Spirk Family Office

George Li
Managing Partner, Proxima Ventures

Sascha Berger
Partner, TVM Capital Life Science

Scott Gazelle
Managing Partner, GreyBird Ventures

Richard Kivel
Managing Director, GrayBella Capital

Oliver Keown
Director, Intuitive Ventures, Intuitive Surgical

Meghana Rao
Senior Manager, New Venture Transactions, Johnson & Johnson Innovation (JLABS)

Alicia Irurzun-Lafitte
Partner, UCB Ventures

Weiyong Sun
Senior Director, Specialty Medicine Search & Evaluation, Daiichi Sankyo

Tad Weems
Managing Director, Agilent Technologies

Nat Brinn
Partner, VC23

Daniella Kranjac
Founding Partner, Dynamk Capital

Lily Kim
Scientific Director, OS Fund

Tom Gibbs
Director, Debiopharm Innovation Fund

Patrik Sobocki
Investment Manager Life Science, Industrifonden

Jeffrey Ries
Managing Director, Healthbox

Chirag Shah
Principal, Define Ventures

Sponsors & Partners

2021 Sponsors

• McDermott Will & Emery
• Life Science Nation

• Medmarc

• Burns Levinson

• FreeMind Consultants
• Big 4 Bio
• Bio Partner
• Israel Export Institute
• Life Sciences Queensland
• Murrieta
• Life Science Intellectual Property Review
• Newton Media Group
• YAFO Capital
• Pitch-N-Ski
• Spark Reach